Report Detail
Global (United States, European Union and China) Antihypertensive Market Research Report 2019-2025
- RnM3683028 |
- 19 August, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Increase in blood pressure is measured in terms of systolic and diastolic blood pressure exerted by blood on the wall of artery and hence it is also termed as arterial hypertension. Reduction in blood pressure minimizes the risk of heart failure, ischaemic heart diseases, dementia and mortality due to hypertension.
Antihypertensives are the drugs that are used to treat high blood pressure. This type of drug alleviate the complications of stroke and myocardial infarction.
In 2019, the market size of Antihypertensive is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antihypertensive.
This report studies the global market size of Antihypertensive, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Antihypertensive sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer
Novartis
Sanofi
Merck
Boehringer Ingelheim
Lupin
Johnson & Johnson
Astra Zeneca
Daiichi Sankyo
Ranbaxy
Market Segment by Product Type
Diuretics
Angiotensin receptor blockers (ARBs)
Angiotensin converting enzyme (ACE) inhibitors
Beta blockers
Alpha blockers
Calcium channel blockers
Renin inhibitors
Vasodilators
Market Segment by Application
Hosptial
Clinic
Home
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Antihypertensive status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Antihypertensive manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Antihypertensive are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Antihypertensive Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Diuretics
- 1.3.3 Angiotensin receptor blockers (ARBs)
- 1.3.4 Angiotensin converting enzyme (ACE) inhibitors
- 1.3.5 Beta blockers
- 1.3.6 Alpha blockers
- 1.3.7 Calcium channel blockers
- 1.3.8 Renin inhibitors
- 1.3.9 Vasodilators
- 1.4 Market Segment by Application
- 1.4.1 Global Antihypertensive Market Share by Application (2019-2025)
- 1.4.2 Hosptial
- 1.4.3 Clinic
- 1.4.4 Home
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Antihypertensive Market Size
- 2.1.1 Global Antihypertensive Revenue 2014-2025
- 2.1.2 Global Antihypertensive Sales 2014-2025
- 2.2 Antihypertensive Growth Rate by Regions
- 2.2.1 Global Antihypertensive Sales by Regions 2014-2019
- 2.2.2 Global Antihypertensive Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Antihypertensive Sales by Manufacturers
- 3.1.1 Antihypertensive Sales by Manufacturers 2014-2019
- 3.1.2 Antihypertensive Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Antihypertensive Revenue by Manufacturers (2014-2019)
- 3.2.2 Antihypertensive Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Antihypertensive Market Concentration Ratio (CR5 and HHI)
- 3.3 Antihypertensive Price by Manufacturers
- 3.4 Key Manufacturers Antihypertensive Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Antihypertensive Market
- 3.6 Key Manufacturers Antihypertensive Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Diuretics Sales and Revenue (2014-2019)
- 4.1.2 Angiotensin receptor blockers (ARBs) Sales and Revenue (2014-2019)
- 4.1.3 Angiotensin converting enzyme (ACE) inhibitors Sales and Revenue (2014-2019)
- 4.1.4 Beta blockers Sales and Revenue (2014-2019)
- 4.1.5 Alpha blockers Sales and Revenue (2014-2019)
- 4.1.6 Calcium channel blockers Sales and Revenue (2014-2019)
- 4.1.7 Renin inhibitors Sales and Revenue (2014-2019)
- 4.1.8 Vasodilators Sales and Revenue (2014-2019)
- 4.2 Global Antihypertensive Sales Market Share by Type
- 4.3 Global Antihypertensive Revenue Market Share by Type
- 4.4 Antihypertensive Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Antihypertensive Sales by Application
6 United States
- 6.1 United States Antihypertensive Breakdown Data by Company
- 6.2 United States Antihypertensive Breakdown Data by Type
- 6.3 United States Antihypertensive Breakdown Data by Application
7 European Union
- 7.1 European Union Antihypertensive Breakdown Data by Company
- 7.2 European Union Antihypertensive Breakdown Data by Type
- 7.3 European Union Antihypertensive Breakdown Data by Application
8 China
- 8.1 China Antihypertensive Breakdown Data by Company
- 8.2 China Antihypertensive Breakdown Data by Type
- 8.3 China Antihypertensive Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Antihypertensive Breakdown Data by Company
- 9.2 Rest of World Antihypertensive Breakdown Data by Type
- 9.3 Rest of World Antihypertensive Breakdown Data by Application
- 9.4 Rest of World Antihypertensive Breakdown Data by Countries
- 9.4.1 Rest of World Antihypertensive Sales by Countries
- 9.4.2 Rest of World Antihypertensive Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Pfizer
- 10.1.1 Pfizer Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Antihypertensive
- 10.1.4 Antihypertensive Product Introduction
- 10.1.5 Pfizer Recent Development
- 10.2 Novartis
- 10.2.1 Novartis Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Antihypertensive
- 10.2.4 Antihypertensive Product Introduction
- 10.2.5 Novartis Recent Development
- 10.3 Sanofi
- 10.3.1 Sanofi Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Antihypertensive
- 10.3.4 Antihypertensive Product Introduction
- 10.3.5 Sanofi Recent Development
- 10.4 Merck
- 10.4.1 Merck Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Antihypertensive
- 10.4.4 Antihypertensive Product Introduction
- 10.4.5 Merck Recent Development
- 10.5 Boehringer Ingelheim
- 10.5.1 Boehringer Ingelheim Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Antihypertensive
- 10.5.4 Antihypertensive Product Introduction
- 10.5.5 Boehringer Ingelheim Recent Development
- 10.6 Lupin
- 10.6.1 Lupin Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Antihypertensive
- 10.6.4 Antihypertensive Product Introduction
- 10.6.5 Lupin Recent Development
- 10.7 Johnson & Johnson
- 10.7.1 Johnson & Johnson Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Antihypertensive
- 10.7.4 Antihypertensive Product Introduction
- 10.7.5 Johnson & Johnson Recent Development
- 10.8 Astra Zeneca
- 10.8.1 Astra Zeneca Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Antihypertensive
- 10.8.4 Antihypertensive Product Introduction
- 10.8.5 Astra Zeneca Recent Development
- 10.9 Daiichi Sankyo
- 10.9.1 Daiichi Sankyo Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Antihypertensive
- 10.9.4 Antihypertensive Product Introduction
- 10.9.5 Daiichi Sankyo Recent Development
- 10.10 Ranbaxy
- 10.10.1 Ranbaxy Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Antihypertensive
- 10.10.4 Antihypertensive Product Introduction
- 10.10.5 Ranbaxy Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Antihypertensive Sales Channels
- 11.2.2 Antihypertensive Distributors
- 11.3 Antihypertensive Customers
12 Market Forecast
- 12.1 Global Antihypertensive Sales and Revenue Forecast 2019-2025
- 12.2 Global Antihypertensive Sales Forecast by Type
- 12.3 Global Antihypertensive Sales Forecast by Application
- 12.4 Antihypertensive Forecast by Regions
- 12.4.1 Global Antihypertensive Sales Forecast by Regions 2019-2025
- 12.4.2 Global Antihypertensive Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Antihypertensive. Industry analysis & Market Report on Antihypertensive is a syndicated market report, published as Global (United States, European Union and China) Antihypertensive Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Antihypertensive market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
